NCT05463848 2026-03-04Surgical Pembro +/- Olaparib w TMZ for rGBMDana-Farber Cancer InstitutePhase 2 Recruiting78 enrolled
NCT03212274 2026-02-19Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 MutationsNational Cancer Institute (NCI)Phase 2 Active not recruiting89 enrolled